PFS Partners’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

PFS Partners’s Portfolio BLPH Stock Details BLPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-6,000	Closed	-$2.39K	–	500
2023 Q3	$2.39K	Hold	6,000	–	–	﹤0.01%	396
2023 Q2	$4.14K	Buy	+6,000	New	+$38.6K	﹤0.01%	375

Other funds holding BLPH

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

PFS Partners's BLPH Position: Q4 2023 in Review

PFS Partners sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q4 2023, closing a stake of 6,000 shares — an estimated $2.39K sold.

PFS Partners first reported a position in BLPH in Q2 2023 and held it in 2 quarters. The position peaked at $4.14K in Q2 2023. 2 funds tracked by Wall St. Rank hold BLPH as of Q4 2023.

PFS Partners reported no remaining Bellerophon Therapeutics, Inc. position as of Q4 2023 after selling out during the quarter.
PFS Partners sold 6,000 Bellerophon Therapeutics, Inc. shares in Q4 2023, an estimated $2.39K.
PFS Partners first reported a position in Bellerophon Therapeutics, Inc. in Q2 2023 and held it in 2 quarters.
PFS Partners's Bellerophon Therapeutics, Inc. position peaked at $4.14K in Q2 2023.
2 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q4 2023.

Based on PFS Partners's 13F filing for Q4 2023, filed 29 Jan 2024.